Literature DB >> 11422189

Therapeutic strategies: rotational therapy and combinations.

P C van de Kerkhof1.   

Abstract

Long-term management of psoriasis requires an individualized approach. Some treatments such as calcipotriol, methotrexate and acitretin may be used as maintenance treatment for many months. However, most anti-psoriasis treatments should be prescribed for restricted periods of time. Rotational treatment is a practical approach to reduce the cumulative toxicity of anti-psoriasis treatments. The selection of a treatment is based on the clinical presentation of psoriasis and whether contraindications might exist. Combination treatment is another approach, which is used by the majority of patients. Useful combinations are calcipotriol-acitretin, calcipotriol-cyclosporin, calcipotriol-PUVA, calcipotriol-topical corticosteroids, dithranol-UVB, dithranol-tar, coaltar-UVB, acitretin-UVB and acitretin-PUVA. Combinations which are contraindicated are coaltar-PUVA, UVB-cyclosporin, PUVA-cyclosporin and methotrexate-acitretin. Combined use of UVB-methotrexate, UVB-PUVA; PUVA-methotrexate; methotrexate-cyclosporin and cyclosporin-acitretin require careful monitoring and might be helpful in patients with severe and recalcitrant psoriasis. Depending on the individual presentation of psoriasis, previous anti-psoriatic treatments and side-effects, treatment adjustments are made.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422189     DOI: 10.1046/j.1365-2230.2001.00829.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  6 in total

Review 1.  Remicade® (infliximab): 20 years of contributions to science and medicine.

Authors:  Richard Melsheimer; Anja Geldhof; Isabel Apaolaza; Thomas Schaible
Journal:  Biologics       Date:  2019-07-30

Review 2.  Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.

Authors:  Gil Yosipovitch; Mark B Y Tang
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Safety of efalizumab therapy in patients with moderate to severe psoriasis: an open-label extension of a phase IIIb trial.

Authors:  Tiffani Hamilton; Alan Menter; Ivor Caro; Peter Compton; Jeffrey Sobell; Kim A Papp
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis.

Authors:  C Leonardi; A Menter; T Hamilton; I Caro; B Xing; A B Gottlieb
Journal:  Br J Dermatol       Date:  2008-03-27       Impact factor: 9.302

Review 5.  Cyclosporine regimens in plaque psoriasis: an overview with special emphasis on dose, duration, and old and new treatment approaches.

Authors:  M D Colombo; N Cassano; G Bellia; G A Vena
Journal:  ScientificWorldJournal       Date:  2013-07-25

Review 6.  Fumaric acid esters in the management of psoriasis.

Authors:  Deepak Mw Balak
Journal:  Psoriasis (Auckl)       Date:  2015-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.